Urticarial reaction following endovascular embolization of an orbital arteriovenous malformation (AVM) with n-butyl cyanoacrylate (nBCA) glue

Abstract

Orbital arteriovenous malformations (AVMs) are rare vascular lesions that may be managed with endovascular embolization followed by surgical resection. Embolization is often accomplished with n-butyl-2-cyanoacrylate (nBCA), which is considered to be a safe and effective liquid occlusive agent. Localized vascular inflammation has been associated with endovascular nBCA use in histopathologic studies, but reports of systemic hypersensitivity reactions following endovascular embolization with nBCA are rare. We present a case of a 26-year-old male who developed an intermittent systemic urticarial reaction without cardiopulmonary compromise beginning four weeks after nBCA embolization of an orbital AVM. Subsequent skin allergy testing performed by an allergist confirmed hypersensitivity to nBCA glue and the patient has since been successfully managed with daily oral antihistamines. Awareness of this rare potential complication of endovascular embolization with nBCA will aid in the counseling and management of patients with AVMs.

Keywords

AVM cyanoacrylate endovascular

Get full access to this article

View all access options for this article.

References

Smoker

Gentry

Yee

et al.

Vascular lesions of the orbit: More than meets the eye. Radiographics 2008; 28: 185–204;. quiz 325.

Rootman

Heran

Graeb

. Vascular malformations of the orbit: Classification and the role of imaging in diagnosis and treatment strategies*. Ophthal Plast Reconstr Surg 2014; 30: 91–104.

Goldberg

Garcia

Duckwiler

. Combined embolization and surgical treatment of arteriovenous malformation of the orbit. Am J Ophthalmol 1993; 116: 17–25.

Rosen

Contractor

. The use of cyanoacrylate adhesives in the management of congenital vascular malformations. Semin Intervent Radiol 2004; 21: 59–66.

Odeyinde

Kangesu

Badran

. Sclerotherapy for vascular malformations: Complications and a review of techniques to avoid them. J Plast Reconstr Aesthetic Surg 2013; 66: 215–223.

Baugh

Basura

Ishii

et al.

Clinical practice guideline: Bell’s palsy. Otolaryngol Head Neck Surg 2013; 149(3 Suppl): S1–S27.

Quinn

Mittal

Baisre

et al.

Vascular inflammation with eosinophils after the use of n-butyl cyanoacrylate liquid embolic system. J Neurointerv Surg 2011; 3: 21–24.

n-BCA Trial Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: Results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002; 23: 748–755.

Advanced Medical Solutions. Cyanoacrylate materials safety data sheet, http://us.liquiband.com/media/43652/cyanoacrylate_msds.pdf (accessed 26 February 2017).

10.

Vanlangenhove

De Keukeleire

Everaert

et al.

Efficacy and safety of two different n-butyl-2-cyanoacrylates for the embolization of varicoceles: A prospective, randomized, blinded study. Cardiovasc Intervent Radiol 2012; 35: 598–606.